title: The low-pH stability discovered in neuraminidase of 1918 pandemic influenza A virus enhances virus replication.
abstract: The "Spanish" pandemic influenza A virus, which killed more than 20 million worldwide in 1918-19, is one of the serious pathogens in recorded history. Characterization of the 1918 pandemic virus reconstructed by reverse genetics showed that PB1, hemagglutinin (HA), and neuraminidase (NA) genes contributed to the viral replication and virulence of the 1918 pandemic influenza virus. However, the function of the NA gene has remained unknown. Here we show that the avian-like low-pH stability of sialidase activity discovered in the 1918 pandemic virus NA contributes to the viral replication efficiency. We found that deletion of Thr at position 435 or deletion of Gly at position 455 in the 1918 pandemic virus NA was related to the low-pH stability of the sialidase activity in the 1918 pandemic virus NA by comparison with the sequences of other human N1 NAs and sialidase activity of chimeric constructs. Both amino acids were located in or near the amino acid resides that were important for stabilization of the native tetramer structure in a low-pH condition like the N2 NAs of pandemic viruses that emerged in 1957 and 1968. Two reverse-genetic viruses were generated from a genetic background of A/WSN/33 (H1N1) that included low-pH-unstable N1 NA from A/USSR/92/77 (H1N1) and its counterpart N1 NA in which sialidase activity was converted to a low-pH-stable property by a deletion and substitutions of two amino acid residues at position 435 and 455 related to the low-pH stability of the sialidase activity in 1918 NA. The mutant virus that included "Spanish Flu"-like low-pH-stable NA showed remarkable replication in comparison with the mutant virus that included low-pH-unstable N1 NA. Our results suggest that the avian-like low-pH stability of sialidase activity in the 1918 pandemic virus NA contributes to the viral replication efficiency.
authors.affiliation: Department of Biochemistry, University of Shizuoka, School of Pharmaceutical Sciences and Global COE Program for Innovation in Human Health Sciences, Shizuoka, Japan.
authors.forename: Tadanobu
authors.initials: T
authors.lastname: Takahashi
authors.forename: Yuuki
authors.initials: Y
authors.lastname: Kurebayashi
authors.forename: Kumiko
authors.initials: K
authors.lastname: Ikeya
authors.forename: Takashi
authors.initials: T
authors.lastname: Mizuno
authors.forename: Keijo
authors.initials: K
authors.lastname: Fukushima
authors.forename: Hiroko
authors.initials: H
authors.lastname: Kawamoto
authors.forename: Yoshihiro
authors.initials: Y
authors.lastname: Kawaoka
authors.forename: Yasuo
authors.initials: Y
authors.lastname: Suzuki
authors.forename: Takashi
authors.initials: T
authors.lastname: Suzuki
mesh_terms: D000596:Amino Acids / Q000737:chemistry; D000818:Animals; D002460:Cell Line; D004285:Dogs; D005434:Flow Cytometry / Q000379:methods; D006801:Humans; D006863:Hydrogen-Ion Concentration; D009980:Influenza A virus / Q000201:enzymology*; D008957:Models, Genetic; D009439:Neuraminidase / Q000378:metabolism / Q000502:physiology*; D058873:Pandemics; D010957:Plasmids / Q000378:metabolism; D011487:Protein Conformation; D014779:Virus Replication
chemical_list: D000596:Amino Acids; D009439:Neuraminidase